Cardiovascular Adverse Events Associated With New-Generation Androgen Receptor Pathway Inhibitors (ARPI) for Prostate Cancer: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS).
Clin Genitourin Cancer
; 21(5): 594-601.e2, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37482524
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Clin Genitourin Cancer
Year:
2023
Document type:
Article